Skip to main content

Advertisement

SpringerLink
Log in

Child with Jaundice and Pruritus: How to Evaluate?

  • Review Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Jaundice with pruritus is a manifestation of cholestasis. The defective biliary drainage causes accumulation of substances that are usually excreted in bile, which in turn causes pruritus. The exact nature of the pruritogen is under evaluation. However, lysophosphatidic acid is the current favourite. The causes of cholestasis can be broadly classified as intra or extrahepatic, with intrahepatic disorders being more often associated with pruritus. Cholestatic phase of acute viral hepatitis, progressive familial intrahepatic cholestasis, syndromic and non-syndromic paucity of intralobular bile ductules, drug induced cholestasis and sclerosing cholangitis (SC) are the common causes in children. An algorithmic approach facilitates early etiological diagnosis by careful clinical evaluation combined with investigations including gamma glutamyl transpeptidase, radiological imaging (ultrasonography, magnetic resonance cholangiopancreatography), liver biopsy and genetic analysis. Management is largely supportive and includes nutritional rehabilitation with supplement of fat soluble vitamins and calcium, stepwise therapy of pruritus with drugs (ursodeoxycholic acid, rifampicin, bile acid sequestrants and/or opioid antagonists) and biliary diversion surgery. Complications of advanced liver disease and portal hypertension need to be addressed. Liver transplantation is required in children with refractory pruritus affecting the quality of life or those with end stage liver disease. Relief of biliary obstruction by endoscopy or surgery and treatment of diseases associated with SC like histiocytosis may be rewarding. Long-term follow-up for development of complications of liver disease and hepatocellular/ cholangiocarcinoma is essential. Thus, an early diagnosis and stepwise treatment with an understanding of the pathogenesis of pruritus in cholestatic disorders may decrease morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.

  2. Beuers U, Kremer AE, Bolier R, Elferink RP. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60:399–407.

    Article  CAS  PubMed  Google Scholar 

  3. Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163–82.

    Article  CAS  PubMed  Google Scholar 

  4. Samanta T, Das AK, Ganguly S. Profile of hepatitis A infection with atypical manifestations in children. Indian J Gastroenterol. 2010;29:31–3.

  5. Saboo AR, Vijaykumar R, Save SU, Bavdekar SB. Prolonged cholestasis following hepatitis A virus infection: revisiting the role of steroids. J Global Infect Dis. 2012;4:185–6.

  6. Ertekin V, Selimoğlu MA, Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei Med J. 2003;44:939–42.

  7. Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4:25–36.

    Article  PubMed  Google Scholar 

  8. Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2008;46:241–52.

    Article  PubMed  Google Scholar 

  9. Kamath BM, Munoz PS, Bab N, et al. A longitudinal study to identify laboratory predictors of liver disease outcome in alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;50:526–30.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Srivastava A, Goel D, Bolia R, Poddar U, Yachha SK. Alagille syndrome: experience of a tertiary care center in north India. Indian J Gastroenterol. 2014;33:59–62.

    Article  PubMed  Google Scholar 

  11. Sinha J, Magid MS, VanHuse C, Thung SN, Suchy F, Kerkar N. Bile duct paucity in infancy. Semin Liver Dis. 2007;27:319–23.

    Article  CAS  PubMed  Google Scholar 

  12. Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011;53:1377–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kerkar N, Miloh T. Sclerosing cholangitis: pediatric perspective. Curr Gastroenterol Rep. 2010;12:195–202.

    Article  PubMed  Google Scholar 

  14. Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E; Studies of Pediatric Liver Transplantation Research Group. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl. 2011;17:925–33.

  15. Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009;7:239–45.

    Article  PubMed  Google Scholar 

  16. Arora NK, Arora S, Ahuja A, et al. Alpha 1 antitrypsin deficiency in children with chronic liver disease in north India. Indian Pediatr. 2010;47:1015–23.

    Article  PubMed  Google Scholar 

  17. Sveger T. Liver disease in α1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294:1316–21.

    Article  CAS  PubMed  Google Scholar 

  18. Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10:S29–36.

    Article  PubMed  Google Scholar 

  19. Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43:S49–55.

    Article  PubMed  Google Scholar 

  20. Subramaniam P, Clayton PT, Portmann BC, Mieli-Vergani G, Hadzić N. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr. 2010;50:61–6.

    Article  CAS  PubMed  Google Scholar 

  21. Makin E, Davenport M. Understanding choledochal malformation. Arch Dis Child. 2012;97:69–72.

    Article  PubMed  Google Scholar 

  22. Kumagi T, Drenth JP, Guttman O, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int. 2012;32:510–8.

    PubMed  Google Scholar 

  23. Krishna RP, Lal R, Sikora SS, Yachha SK, Pal L. Unusual causes of extrahepatic biliary obstruction in children: a case series with review of literature. Pediatr Surg Int. 2008;24:183–90.

    Article  PubMed  Google Scholar 

  24. Pryor JP, Volpe CM, Caty MG, Doerr RJ. Noncalculous biliary obstruction in the child and adolescent. J Am Coll Surg. 2000;191:569–78.

    Article  CAS  PubMed  Google Scholar 

  25. Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004;8:67–81.

    Article  PubMed  Google Scholar 

  26. Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009;50:808–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chapman R, Fevery J, Kalloo A, et al; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.

  28. Balistreri WF. Bile acid therapy in pediatric Hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997;24:573–89.

    Article  CAS  PubMed  Google Scholar 

  29. Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 1997;25:519–23.

    Article  CAS  PubMed  Google Scholar 

  30. Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50:323–32.

    CAS  PubMed  Google Scholar 

  31. El-Karaksy H, Mansour S, El-Sayed R, El-Raziky M, El-Koofy N, Taha G. Safety and efficacy of rifampicin in children with cholestatic pruritus. Indian J Pediatr. 2007;74:279–81.

    Article  PubMed  Google Scholar 

  32. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990;98:1013–6.

    Article  CAS  PubMed  Google Scholar 

  33. Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 1992;102:544–9.

    Article  CAS  PubMed  Google Scholar 

  34. Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr. 2010;51:787–9.

    Article  PubMed  Google Scholar 

  35. Müller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol. 1998;10:865–70.

    Article  PubMed  Google Scholar 

  36. Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with Alagille syndrome: the King’s college hospital experience. J Pediatr Gastroenterol Nutr. 2013;57:149–54.

  37. O’Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R. A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther. 2005;21:1041–5.

    Article  CAS  PubMed  Google Scholar 

  38. Montero JL, Pozo JC, Barrera P, et al. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Transplant Proc. 2006;38:2511–3.

    Article  CAS  PubMed  Google Scholar 

  39. Ng VL, Ryckman FC, Porta G, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2000;30:152–6.

    Article  CAS  PubMed  Google Scholar 

  40. Nightingale S, Lee NV. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin N Am. 2009;56:1161–83.

    Article  Google Scholar 

  41. Carrion AF, Bhamidimarri KR. Liver transplant for cholestatic liver diseases. Clin Liver Dis. 2013;17:345–59.

    Article  PubMed  Google Scholar 

Download references

Contributions

Both the authors contributed to the literature search, writing the manuscript and approve the final draft of the manuscript. AS will act as guarantor for the paper.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India

    Barath Jagadisan

  2. Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014, Uttar Pradesh, India

    Anshu Srivastava

Authors
  1. Barath Jagadisan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anshu Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anshu Srivastava.

Ethics declarations

Conflict of Interest

None.

Source of Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jagadisan, B., Srivastava, A. Child with Jaundice and Pruritus: How to Evaluate?. Indian J Pediatr 83, 1311–1320 (2016). https://doi.org/10.1007/s12098-016-2058-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-016-2058-6

Keywords

Search

Navigation